These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 385500)

  • 1. Experimental gram-negative bacterial sepsis: prevention of mortality not preventable by antibiotics alone.
    Greisman SE; DuBuy JB; Woodward CL
    Infect Immun; 1979 Aug; 25(2):538-57. PubMed ID: 385500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endotoxemia induced by antibiotic therapy: a mechanism for adrenal corticosteroid protection in gram-negative sepsis.
    Johnston CA; Greisman SE
    Trans Assoc Am Physicians; 1984; 97():172-81. PubMed ID: 6398946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental gram-negative bacterial sepsis: reevaluation of the ability of rough mutant antisera to protect mice.
    Greisman SE; DuBuy JB; Woodward CL
    Proc Soc Exp Biol Med; 1978 Jul; 158(3):482-90. PubMed ID: 356058
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibody to cell wall glycolipid of Gram-negative bacteria: induction of immunity to bacteremia and endotoxemia.
    Braude AI; Ziegler EJ; Douglas H; McCutchan JA
    J Infect Dis; 1977 Aug; 136 Suppl():S167-73. PubMed ID: 330776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human antiserum for prevention of the local shwartzman reaction and death from bacterial lipopolysaccharides.
    Ziegler EJ; Douglas H; Braude AI
    J Clin Invest; 1973 Dec; 52(12):3236-8. PubMed ID: 4584346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiserum against Escherichia coli J5: a re-evaluation of its in vitro and in vivo activity against heterologous gram-negative bacteria.
    Trautmann M; Hahn H
    Infection; 1985; 13(3):140-5. PubMed ID: 3897069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for antibiotic-mediated endotoxin release as a contributing factor to lethality in experimental gram-negative sepsis.
    Morrison DC; Bucklin SE
    Scand J Infect Dis Suppl; 1996; 101():3-8. PubMed ID: 9060044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid Freezing Enables Aminoglycosides To Eradicate Bacterial Persisters via Enhancing Mechanosensitive Channel MscL-Mediated Antibiotic Uptake.
    Zhao Y; Lv B; Sun F; Liu J; Wang Y; Gao Y; Qi F; Chang Z; Fu X
    mBio; 2020 Feb; 11(1):. PubMed ID: 32047133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inadequate timing between corticosteroid and antibiotics applications increases mortality due to sepsis.
    Fadel MV; Repka JC; Cunha CL; Leão MT
    Braz J Infect Dis; 2008 Oct; 12(5):416-22. PubMed ID: 19219282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental Gram-negative bacterial sepsis: optimal methylprednisolone requirements for prevention of mortality not preventable by antibiotics alone.
    Greisman SE
    Proc Soc Exp Biol Med; 1982 Sep; 170(4):436-42. PubMed ID: 6750617
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of aminoglycoside inhibition and reduction of capsular polysaccharide production in Klebsiella pneumoniae by sodium salicylate.
    Domenico P; Hopkins T; Schoch PE; Cunha BA
    J Antimicrob Chemother; 1990 Jun; 25(6):903-14. PubMed ID: 2196259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with rough mutants of Salmonella minnesota. IV. Protection by antisera to O and rough antigens against endotoxin.
    Johns M; Skehill A; McCabe WR
    J Infect Dis; 1983 Jan; 147(1):57-67. PubMed ID: 6185599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic induced endotoxin release and clinical sepsis: a review.
    Holzheimer RG
    J Chemother; 2001 Nov; 13 Spec No 1(1):159-72. PubMed ID: 11936361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The susceptibility of mice to bacterial endotoxins.
    SCHAEDLER RW; DUBOS RJ
    J Exp Med; 1961 Mar; 113(3):559-70. PubMed ID: 13747161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational use of aminoglycosides--review and recommendations by the Swedish Reference Group for Antibiotics (SRGA).
    Hanberger H; Edlund C; Furebring M; G Giske C; Melhus A; Nilsson LE; Petersson J; Sjölin J; Ternhag A; Werner M; Eliasson E;
    Scand J Infect Dis; 2013 Mar; 45(3):161-75. PubMed ID: 23270477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-reactive antigens: their potential for immunization-induced immunity to Gram-negative bacteria.
    McCabe WR; Bruins SC; Craven DE; Johns M
    J Infect Dis; 1977 Aug; 136 Suppl():S161-6. PubMed ID: 330775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumannii.
    Juhas M; Widlake E; Teo J; Huseby DL; Tyrrell JM; Polikanov YS; Ercan O; Petersson A; Cao S; Aboklaish AF; Rominski A; Crich D; Böttger EC; Walsh TR; Hughes D; Hobbie SN
    J Antimicrob Chemother; 2019 Apr; 74(4):944-952. PubMed ID: 30629184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the protective effects of hyperimmune immunoglobulins G and M against endotoxin in mice and rats.
    Nys M; Damas J; Damas P; Laub R; Cloes JM; Lamy M
    Med Microbiol Immunol; 1999 Nov; 188(2):55-64. PubMed ID: 10753056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of plazomicin in combination with other antibiotics against multidrug-resistant Enterobacteriaceae.
    Thwaites M; Hall D; Stoneburner A; Shinabarger D; Serio AW; Krause KM; Marra A; Pillar C
    Diagn Microbiol Infect Dis; 2018 Dec; 92(4):338-345. PubMed ID: 30097297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.